Novo Holdings A/S - Feb 23, 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Novo Holdings A/S
Stock symbol
CMPI
Transactions as of
Feb 23, 2022
Transactions value $
-$23,067
Form type
4
Date filed
2/25/2022, 05:21 PM
Previous filing
Feb 9, 2022
Next filing
Jul 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPI Common Stock Sale -$5.28K -1.82K -0.08% $2.90 2.17M Feb 23, 2022 Direct
transaction CMPI Common Stock Sale -$17K -5.99K -0.28% $2.83 2.16M Feb 24, 2022 Direct F1
transaction CMPI Common Stock Sale -$811 -300 -0.01% $2.70 2.16M Feb 25, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.79 to $2.91. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price noted in this footnote.